| 1. |
|
|
| 2. |
- Bravo, L, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 3. |
- Tabiri, S, et al.
(författare)
-
- 2021
-
swepub:Mat__t
|
|
| 4. |
- Khatri, C, et al.
(författare)
-
Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study
- 2021
-
Ingår i: BMJ open. - : BMJ. - 2044-6055. ; 11:11, s. e050830-
-
Tidskriftsartikel (refereegranskat)abstract
- Studies have demonstrated high rates of mortality in people with proximal femoral fracture and SARS-CoV-2, but there is limited published data on the factors that influence mortality for clinicians to make informed treatment decisions. This study aims to report the 30-day mortality associated with perioperative infection of patients undergoing surgery for proximal femoral fractures and to examine the factors that influence mortality in a multivariate analysis.SettingProspective, international, multicentre, observational cohort study.ParticipantsPatients undergoing any operation for a proximal femoral fracture from 1 February to 30 April 2020 and with perioperative SARS-CoV-2 infection (either 7 days prior or 30-day postoperative).Primary outcome30-day mortality. Multivariate modelling was performed to identify factors associated with 30-day mortality.ResultsThis study reports included 1063 patients from 174 hospitals in 19 countries. Overall 30-day mortality was 29.4% (313/1063). In an adjusted model, 30-day mortality was associated with male gender (OR 2.29, 95% CI 1.68 to 3.13, p<0.001), age >80 years (OR 1.60, 95% CI 1.1 to 2.31, p=0.013), preoperative diagnosis of dementia (OR 1.57, 95% CI 1.15 to 2.16, p=0.005), kidney disease (OR 1.73, 95% CI 1.18 to 2.55, p=0.005) and congestive heart failure (OR 1.62, 95% CI 1.06 to 2.48, p=0.025). Mortality at 30 days was lower in patients with a preoperative diagnosis of SARS-CoV-2 (OR 0.6, 95% CI 0.6 (0.42 to 0.85), p=0.004). There was no difference in mortality in patients with an increase to delay in surgery (p=0.220) or type of anaesthetic given (p=0.787).ConclusionsPatients undergoing surgery for a proximal femoral fracture with a perioperative infection of SARS-CoV-2 have a high rate of mortality. This study would support the need for providing these patients with individualised medical and anaesthetic care, including medical optimisation before theatre. Careful preoperative counselling is needed for those with a proximal femoral fracture and SARS-CoV-2, especially those in the highest risk groups.Trial registration numberNCT04323644
|
|
| 5. |
- Abbas, Ghazanfar, et al.
(författare)
-
Electrochemical investigation of mixed metal oxide nanocomposite electrode for low temperature solid oxide fuel cell
- 2017
-
Ingår i: International Journal of Modern Physics B. - : WORLD SCIENTIFIC PUBL CO PTE LTD. - 0217-9792. ; 31:27
-
Tidskriftsartikel (refereegranskat)abstract
- Zinc-based nanostructured nickel (Ni) free metal oxide electrode material Zn-0.60/CU0.20Mn0.20 oxide (CMZO) was synthesized by solid state reaction and investigated for low temperature solid oxide fuel cell (LTSOFC) applications. The crystal structure and surface morphology of the synthesized electrode material were examined by XRD and SEM techniques respectively. The particle size of ZnO phase estimated by Scherer's equation was 31.50 nm. The maximum electrical conductivity was found to be 12.567 S/cm and 5.846 S/cm in hydrogen and air atmosphere, respectively at 600 degrees C. The activation energy of the CMZO material was also calculated from the DC conductivity data using Arrhenius plots and it was found to be 0.060 and 0.075 eV in hydrogen and air atmosphere, respectively. The CMZO electrode-based fuel cell was tested using carbonated samarium doped ceria composite (NSDC) electrolyte. The three layers 13 mm in diameter and 1 mm thickness of the symmetric fuel cell were fabricated by dry pressing. The maximum power density of 728.86 mW/cm(2) was measured at 550 degrees C.
|
|
| 6. |
|
|
| 7. |
- Abbas, Ghazanfar, et al.
(författare)
-
Synthesize and characterization of nanocomposite anodes for low temperature solid oxide fuel cell
- 2015
-
Ingår i: International journal of hydrogen energy. - : Elsevier BV. - 0360-3199 .- 1879-3487. ; 40:1, s. 891-897
-
Tidskriftsartikel (refereegranskat)abstract
- Solid oxide fuel cells have much capability to become an economical alternative energy conversion technology having appropriate materials that can be operated at comparatively low temperature in the range of 400-600 degrees C. The nano-scale engineering has been incorporated to improve the catalytic activity of anode materials for solid oxide fuel cells. Nanostructured Al0.10NixZn0.90-xO oxides were prepared by solid state reaction, which were then mixed with the prepared Gadolinium doped Ceria GDC electrolyte. The crystal structure and surface morphology were characterized by XRD and SEM. The particle size was evaluated by XRD data and found in the range of 20-50 nm, which was then ensured by SEM pictures. The pellets of 13 mm diameter were pressed by dry press technique and electrical conductivities (DC and AC) were determined by four probe techniques and the values have been found to be 10.84 and 4.88 S/cm, respectively at hydrogen atmosphere in the temperature range of 300-600 degrees C. The Electrochemical Impedance Spectroscopy (EIS) analysis exhibits the pure electronic behavior at hydrogen atmosphere. The maximum power density of ANZ-GDC composite anode based solid oxide fuel cell has been achieved 705 mW/cm(2) at 550 degrees C.
|
|
| 8. |
|
|
| 9. |
- Reinert, Line S, et al.
(författare)
-
Brain immune cells undergo cGAS-STING-dependent apoptosis during herpes simplex virus type 1 infection.
- 2020
-
Ingår i: The Journal of clinical investigation. - 1558-8238. ; 131:1
-
Tidskriftsartikel (refereegranskat)abstract
- Protection of the brain from viral infections involves the type I interferon (IFN-I) system, defects in which renders humans susceptible to herpes simplex encephalitis (HSE). However, excessive cerebral IFN-I levels leads to pathologies, suggesting the need for tight regulation of responses. Based on data from mouse models, human HSE cases, and primary cell culture systems, we here show that microglia and other immune cells undergo apoptosis in the HSV-1-infected brain through a mechanism dependent on the cyclic GMP-AMP synthase (cGAS) - stimulator of interferon genes (STING) pathway, but independent of IFN-I. HSV-1 infection of microglia induced cGAS-dependent apoptosis at high viral doses, while lower viral doses led to IFN-I responses. Importantly, inhibition of caspase activity prevented microglial cell death and augmented IFN-I responses. Accordingly, HSV-1-infected organotypic brain slices, or mice treated with caspase inhibitor, exhibited lower viral load and improved outcome of infection. Collectively, we identify an activation-induced apoptosis program in brain immune cells which down-modulates local immune responses.
|
|
| 10. |
-
- 2019
-
Tidskriftsartikel (refereegranskat)
|
|
